BioCryst Pharmaceuticals Inc (BCRX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 79.55M | 68.78M | 82.49M | 86.74M | 93.4M | 92.76M | 109.33M | 117.09M |
営業利益 | -46.31M | -28.42M | -20.7M | -19.26M | -42.67M | -14.49M | 8.76M | 7.69M |
税引前収入 | -71.47M | -52.66M | -74.59M | -35.82M | -63.16M | -35.01M | -12.5M | -13.45M |
純利益 | -71.54M | -53.33M | -75.33M | -36.15M | -61.73M | -35.38M | -12.67M | -14.03M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -46.31M | -28.42M | -20.7M | -19.26M | -42.67M | -14.49M | 8.76M | 7.69M |
EBITDA | -45.92M | -28.01M | -20.3M | -18.84M | -40.7M | -14.18M | 9.08M | 8M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 26.35M | 25.19M | 20.65M | 48.84M | 17.81M | 157.17M | 270.83M | 331.41M |
営業利益 | -48.61M | -57.41M | -94.22M | -99.46M | -174.76M | -177.72M | -148.44M | -103.71M |
税引前収入 | -55.14M | -65.78M | -101.25M | -108.9M | -182.81M | -181.81M | -244.38M | -226.23M |
純利益 | -55.14M | -65.78M | -101.25M | -108.9M | -182.81M | -184.06M | -247.12M | -226.54M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.747 | -0.668 | -0.92 | -0.707 | -1.034 | -0.998 | -1.315 | -1.106 |
EBIT | -48.61M | -57.41M | -94.22M | -99.46M | -176.77M | -177.72M | -148.44M | -103.71M |
EBITDA | -48.12M | -56.71M | -93.45M | -98.73M | -174.01M | -176.94M | -147M | -100.51M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約